Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C NEWTON

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Bioorganic & Medicinal Chemistry|September 1, 1994
Selective non-peptide ligands for an accommodating peptide receptor. Imidazobenzodiazepines as potent cholecystokinin type B receptor antagonistsM G Bock, R M DiPardo, R C Newton, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2000
Phenylacetamides as selective alpha-1A adrenergic receptor antagonistsM A Patane, R M DiPardo, R C Newton, et al.
Journal of Medicinal Chemistry|October 5, 2001
Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha releaseC B Xue, X He, R L Corbett, et al.
The Journal of Biological Chemistry|August 7, 1999
Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS familyI Abbaszade, R Q Liu, F Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2001
Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-alphaP H Carter, P A Scherle, J K Muckelbauer, et al.
Science (New York, N.Y.)|June 5, 1999
Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteinsM D Tortorella, T C Burn, M A Pratta, et al.
Journal of Medicinal Chemistry|July 27, 2001
Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivoC B Xue, M E Voss, D J Nelson, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Bioorganic & Medicinal Chemistry|September 1, 1994
Selective non-peptide ligands for an accommodating peptide receptor. Imidazobenzodiazepines as potent cholecystokinin type B receptor antagonistsM G Bock, R M DiPardo, R C Newton, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2000
Phenylacetamides as selective alpha-1A adrenergic receptor antagonistsM A Patane, R M DiPardo, R C Newton, et al.
Journal of Medicinal Chemistry|October 5, 2001
Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha releaseC B Xue, X He, R L Corbett, et al.
The Journal of Biological Chemistry|August 7, 1999
Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS familyI Abbaszade, R Q Liu, F Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2001
Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-alphaP H Carter, P A Scherle, J K Muckelbauer, et al.
Science (New York, N.Y.)|June 5, 1999
Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteinsM D Tortorella, T C Burn, M A Pratta, et al.
Journal of Medicinal Chemistry|July 27, 2001
Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivoC B Xue, M E Voss, D J Nelson, et al.
Pageof 7